1. Home
  2. SIEB vs INMB Comparison

SIEB vs INMB Comparison

Compare SIEB & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Siebert Financial Corp.

SIEB

Siebert Financial Corp.

HOLD

Current Price

$2.21

Market Cap

68.4M

Sector

Finance

ML Signal

HOLD

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$2.29

Market Cap

64.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIEB
INMB
Founded
1886
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.4M
64.7M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
SIEB
INMB
Price
$2.21
$2.29
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.40
AVG Volume (30 Days)
79.4K
322.7K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.85
EPS
N/A
N/A
Revenue
$94,202,000.00
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.28
257.14
52 Week Low
$1.53
$1.09
52 Week High
$4.14
$2.60

Technical Indicators

Market Signals
Indicator
SIEB
INMB
Relative Strength Index (RSI) 50.11 54.03
Support Level $1.64 $2.21
Resistance Level $2.29 $2.55
Average True Range (ATR) 0.16 0.16
MACD -0.05 -0.03
Stochastic Oscillator 21.31 57.48

Price Performance

Historical Comparison
SIEB
INMB

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm engaged in providing brokerage and financial advisory services. The coperates through two segments: Financial Services and Media, Sports and Entertainment. The Financial Services segment mainly operates as a securities broker-dealer and provides brokerage, custody, and clearing services for retail accounts, as well as insurance and advisory services, principal and proprietary trading, market making, securities lending, and investment banking and capital markets services. The Media, Sports and Entertainment segment is engaged in the production and distribution of music and media content, as well as talent management and sports representation. It generates the majority of its revenue from the Financial Services segment.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: